Press Releases
Ethris Adds Three New Members to its Board of Directors
Leon Chen (OrbiMed), Thomas Chalberg (Oncorus, Inc.) and Justin Duckworth (HS LifeSciences) Join Ethris’ Board to Support Next Stage of Company’s Development. Ethris GmbH, a pioneer in the emerging field of messenger RNA (mRNA) therapies, [...]
Ethris moves to new facility
Since March 23, 2015, Ethris operates in a brand new building in Planegg. The new facility offers 1,500 square meters of lab and office space. Moving there has offered the opportunity to design the laboratories [...]
Research project of € 3.2 million is among the winners of the BMBF call “Go-Bio”
With its project “SNIM® RNA – a new class of RNA biopharmaceuticals” Ethris is among the winners of the 4th Selection round of the “Go-Bio” call funded by the Federal Ministry of Education and Research [...]